# Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles

> **NCT06150703** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 652 (estimated)

## Conditions studied

- In Vitro Fertilization
- ICSI Intracytoplasmic Spermatozoid Injection

## Interventions

- **DRUG:** Ovulation induction with hCG + Luteal phase support with vaginal progesterone
- **DRUG:** Ovulation triggering by Triptorelin + Luteal phase support by Nafarelin

## Key facts

- **NCT ID:** NCT06150703
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-27
- **Primary completion:** 2027-09
- **Final completion:** 2027-09-27
- **Target enrollment:** 652 (ESTIMATED)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06150703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06150703, "Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06150703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*